SlideShare a Scribd company logo
Capsules as medical devices
Capsules as medical devices
Capsules as medical devices
Capsules as medical devices

More Related Content

More from Generic Pharma 2.0

GP20 Licensing Pavillion 2012 Coexhibitor Kit
GP20 Licensing Pavillion 2012 Coexhibitor KitGP20 Licensing Pavillion 2012 Coexhibitor Kit
GP20 Licensing Pavillion 2012 Coexhibitor KitGeneric Pharma 2.0
 
BioSimilar Drug Development World
BioSimilar Drug Development WorldBioSimilar Drug Development World
BioSimilar Drug Development WorldGeneric Pharma 2.0
 
Your Ideal Pfizer
Your Ideal PfizerYour Ideal Pfizer
Your Ideal Pfizer
Generic Pharma 2.0
 
Animal health
Animal healthAnimal health
Animal health
Generic Pharma 2.0
 
Moving @ the Speed of Social
Moving @ the Speed of SocialMoving @ the Speed of Social
Moving @ the Speed of Social
Generic Pharma 2.0
 
New Pharma Magazine Seeking Contributors
New Pharma Magazine Seeking ContributorsNew Pharma Magazine Seeking Contributors
New Pharma Magazine Seeking ContributorsGeneric Pharma 2.0
 
OTC Licensing Product Portfolio
OTC Licensing Product PortfolioOTC Licensing Product Portfolio
OTC Licensing Product Portfolio
Generic Pharma 2.0
 
LinkedIn Survey Results
LinkedIn Survey ResultsLinkedIn Survey Results
LinkedIn Survey Results
Generic Pharma 2.0
 
CPHI 2012! Generic Pharma 2.0 Stand Design
CPHI 2012! Generic Pharma 2.0 Stand DesignCPHI 2012! Generic Pharma 2.0 Stand Design
CPHI 2012! Generic Pharma 2.0 Stand DesignGeneric Pharma 2.0
 
New Pharma Magazine
New Pharma MagazineNew Pharma Magazine
New Pharma Magazine
Generic Pharma 2.0
 
Woerwag RD presentation
Woerwag RD presentationWoerwag RD presentation
Woerwag RD presentation
Generic Pharma 2.0
 
Neogen presentation april_2011_gl
Neogen presentation april_2011_glNeogen presentation april_2011_gl
Neogen presentation april_2011_gl
Generic Pharma 2.0
 
Genericlicensing.com - featured companies 2011
Genericlicensing.com - featured companies 2011Genericlicensing.com - featured companies 2011
Genericlicensing.com - featured companies 2011Generic Pharma 2.0
 
2011 Global Generic Product Directory Demo
2011 Global Generic Product Directory Demo2011 Global Generic Product Directory Demo
2011 Global Generic Product Directory Demo
Generic Pharma 2.0
 
Heal gel presentation
Heal gel presentationHeal gel presentation
Heal gel presentation
Generic Pharma 2.0
 
Biosimilars - analysing market intelligence (Peter Wittner)
Biosimilars - analysing market intelligence (Peter Wittner)Biosimilars - analysing market intelligence (Peter Wittner)
Biosimilars - analysing market intelligence (Peter Wittner)Generic Pharma 2.0
 
GSK and Siemens continuous tablet manufacture
GSK and Siemens continuous tablet manufactureGSK and Siemens continuous tablet manufacture
GSK and Siemens continuous tablet manufactureGeneric Pharma 2.0
 
Generic Licensing Pavillion @ CPhI WW 2011
Generic Licensing Pavillion @ CPhI WW 2011Generic Licensing Pavillion @ CPhI WW 2011
Generic Licensing Pavillion @ CPhI WW 2011
Generic Pharma 2.0
 
Opportunities and barriers in the biosimilar marketevolution or revolution fo...
Opportunities and barriers in the biosimilar marketevolution or revolution fo...Opportunities and barriers in the biosimilar marketevolution or revolution fo...
Opportunities and barriers in the biosimilar marketevolution or revolution fo...Generic Pharma 2.0
 

More from Generic Pharma 2.0 (20)

GP20 Licensing Pavillion 2012 Coexhibitor Kit
GP20 Licensing Pavillion 2012 Coexhibitor KitGP20 Licensing Pavillion 2012 Coexhibitor Kit
GP20 Licensing Pavillion 2012 Coexhibitor Kit
 
BioSimilar Drug Development World
BioSimilar Drug Development WorldBioSimilar Drug Development World
BioSimilar Drug Development World
 
Your Ideal Pfizer
Your Ideal PfizerYour Ideal Pfizer
Your Ideal Pfizer
 
Animal health
Animal healthAnimal health
Animal health
 
Moving @ the Speed of Social
Moving @ the Speed of SocialMoving @ the Speed of Social
Moving @ the Speed of Social
 
New Pharma Magazine Seeking Contributors
New Pharma Magazine Seeking ContributorsNew Pharma Magazine Seeking Contributors
New Pharma Magazine Seeking Contributors
 
OTC Licensing Product Portfolio
OTC Licensing Product PortfolioOTC Licensing Product Portfolio
OTC Licensing Product Portfolio
 
LinkedIn Survey Results
LinkedIn Survey ResultsLinkedIn Survey Results
LinkedIn Survey Results
 
CPHI 2012! Generic Pharma 2.0 Stand Design
CPHI 2012! Generic Pharma 2.0 Stand DesignCPHI 2012! Generic Pharma 2.0 Stand Design
CPHI 2012! Generic Pharma 2.0 Stand Design
 
GL infographics
GL infographicsGL infographics
GL infographics
 
New Pharma Magazine
New Pharma MagazineNew Pharma Magazine
New Pharma Magazine
 
Woerwag RD presentation
Woerwag RD presentationWoerwag RD presentation
Woerwag RD presentation
 
Neogen presentation april_2011_gl
Neogen presentation april_2011_glNeogen presentation april_2011_gl
Neogen presentation april_2011_gl
 
Genericlicensing.com - featured companies 2011
Genericlicensing.com - featured companies 2011Genericlicensing.com - featured companies 2011
Genericlicensing.com - featured companies 2011
 
2011 Global Generic Product Directory Demo
2011 Global Generic Product Directory Demo2011 Global Generic Product Directory Demo
2011 Global Generic Product Directory Demo
 
Heal gel presentation
Heal gel presentationHeal gel presentation
Heal gel presentation
 
Biosimilars - analysing market intelligence (Peter Wittner)
Biosimilars - analysing market intelligence (Peter Wittner)Biosimilars - analysing market intelligence (Peter Wittner)
Biosimilars - analysing market intelligence (Peter Wittner)
 
GSK and Siemens continuous tablet manufacture
GSK and Siemens continuous tablet manufactureGSK and Siemens continuous tablet manufacture
GSK and Siemens continuous tablet manufacture
 
Generic Licensing Pavillion @ CPhI WW 2011
Generic Licensing Pavillion @ CPhI WW 2011Generic Licensing Pavillion @ CPhI WW 2011
Generic Licensing Pavillion @ CPhI WW 2011
 
Opportunities and barriers in the biosimilar marketevolution or revolution fo...
Opportunities and barriers in the biosimilar marketevolution or revolution fo...Opportunities and barriers in the biosimilar marketevolution or revolution fo...
Opportunities and barriers in the biosimilar marketevolution or revolution fo...